Education
About Us
Working with TipRanks
Follow Us
Cyfuse Biomedical K.K. (JP:4892)
:4892
See the Price Targets and Ratings of:
4892 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
¥891
Hold
35.20%
Upside
Reiterated
07/03/25
The overall stock score reflects the significant financial and technical challenges facing the company. Persistent financial losses, negative cash flows, and bearish technical indicators are the primary factors influencing this score. The negative P/E ratio exacerbates valuation concerns, making it a high-risk investment.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
¥891
Hold
35.20%
Upside
Reiterated
07/03/25
The overall stock score reflects the significant financial and technical challenges facing the company. Persistent financial losses, negative cash flows, and bearish technical indicators are the primary factors influencing this score. The negative P/E ratio exacerbates valuation concerns, making it a high-risk investment.
4892 Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
Buy
0
0
0
Hold
3
4
6
Sell
0
0
0
Strong Sell
0
0
0
total
3
4
6
Each month's total comprises the sum of three months' worth of ratings.
4892 Stock Forecast FAQ
What is JP:4892’s average 12-month price target, according to analysts?
Based on analyst ratings, Cyfuse Biomedical K.K.’s 12-month average price target is 891.00.
What is JP:4892’s upside potential, based on the analysts’ average price target?
Cyfuse Biomedical K.K. has 35.20% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cyfuse Biomedical K.K. a Buy, Sell or Hold?
Cyfuse Biomedical K.K. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Cyfuse Biomedical K.K.’s share price target?
The average share price target for Cyfuse Biomedical K.K. is 891.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ¥891.00 ,and the lowest forecast is ¥891.00. The average share price target represents 35.20% Increase from the current price of ¥659.
The highest analyst share price target is ¥891.00 ,and the lowest forecast is ¥891.00. The average share price target represents 35.20% Increase from the current price of ¥659.
What do analysts say about Cyfuse Biomedical K.K.?
Cyfuse Biomedical K.K.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Cyfuse Biomedical K.K.?
To buy shares of JP:4892, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.